ArticleCancer science2017

Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells.

Justyna Kutkowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.